Overtreatment of prostate cancer in the active surveillance era
Common Sense Family Doctor
DECEMBER 14, 2024
Surveillance, Epidemiology, and End-Results (SEER) prostate cancer database found that among men with intermediate-risk prostate cancer (based on pathology and a PSA level lower than 20 ng/mL), active surveillance or watchful waiting increased overall from 5% in 2010 to 12.3% and 6.1%, respectively).
Let's personalize your content